(Q58622787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

title

Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Dominique Thabut

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ariane Chryssostalis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Julien Taieb

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Vlad Ratziu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

518-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Adrenocorticosteroid therapy and peptic-ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Adrenocorticosteroid administration and peptic ulcer: a critical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900045-X

7 January 2021

10.1016/S0168-8278(03)00045-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663246%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference